Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock factor binding protein 1 pseudogene 2 (HSBP1P2) is classified as a pseudogene, as indexed by gene resources such as NCBI Gene. As a pseudogene, HSBP1P2 is a genomic DNA sequence similar to the functional gene (in this case, Heat shock factor binding protein 1, HSBP1) but is considered non-functional due to mutations, lack of regulatory elements, or failure to encode a functional protein. While some pseudogenes have been shown in research to play regulatory roles through non-coding RNA transcripts—such as acting as miRNA decoys or influencing mRNA stability—there is no evidence that HSBP1P2 itself is functional or has established biological or clinical relevance. There are no reported drug interactions, mechanisms of action, biomarker status, or safety concerns associated with HSBP1P2. However, the field continues to evolve, and some pseudogenes have eventually been reclassified as protein-coding or regulatory elements when functional evidence emerges. Summary of quality/integrity: - HSBP1P2 is not a receptor, enzyme, transporter, or typical therapeutic target, and there is no evidence of biological or clinical utility. - The gene is correctly named for a specific human pseudogene; however, it is not suitable as a drug target. Notes: - The parent gene, HSBP1 (heat shock factor binding protein 1), is a functional protein involved in the negative regulation of heat shock factor 1 (HSF1) and the heat shock response, but this does not apply to HSBP1P2, the pseudogene. - If you seek a druggable target, investigate HSF1, HSF2, or HSBP1, not HSBP1P2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock factor binding protein 1 pseudogene 2 (HSBP1P2).